Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

NCT04530071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Low-back Pain
Disc Degeneration

Interventions

BIOLOGICAL: CordSTEM-DD (0.7 x 10^7 cells)
BIOLOGICAL: CordSTEM-DD (2.1 x 10^7 cells)
BIOLOGICAL: Placebo

Sponsor

CHABiotech CO., Ltd

Collaborators

[object Object]